---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083131"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T19:14:47.692518+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Sarepta shareholders approve 4.3M share increase to 2018 equity plan, 0.3M to ESPP

## Summary
- Vote approves adding 4,300,000 shares to 2018 Equity Incentive Plan (total now 17,487,596).
- Vote approves adding 300,000 shares to 2016 ESPP (total now 1,700,000 shares).
- Re-elected directors Barry, Behrens, Mayo, Nicaise with majority support.
- Advisory vote on 2024 named executive officer compensation passed (72.1M for, 2.2M against).
- Ratified KPMG as independent auditor for FY2025 (80.6M for, 3.9M against).

## SEC filing metadata
- accession: 0000950170-25-083131
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/0000950170-25-083131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/srpt-20250605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083131
- JSON: https://secwatch.observer/filing/0000950170-25-083131.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083131.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.